Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cisatracurium Monitoring vs Clinical Assessment in Critical Illness
NCT03198637Phase 3Completed
- Sponsor
- CHU de Poitiers
- Start
- Apr 2013
- Primary completion
- May 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of cisatracurium in critical illness, sponsored by CHU de Poitiers. Started Apr 2013; status: completed.
02
Drugs
cisatracurium
03
Conditions
critical illness
Beyond the preview
Go deeper on NCT03198637.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03198637.